Devimistat (CPI-613)

Ask supplier a question | View on supplier's website

Devimistat (CPI-613), a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase in NCI-H460 cell line, disrupts tumor cell mitochondrial metabolism. CPI-613 induces apoptosis in pancreatic cancer cells. Phase 2.

Supplier	Selleck Chemicals
Product #	S2776
Sku #	S2776-5mg
Pricing	5mg, $79.00

Feedback